Introduction: Variability in severity of Respiratory Syncytial Virus (RSV) infection is reportedly due to differences in inflammatory response. Objective: To characterize the cytokine response in RSV+ infants aged 0 -36 months and to relate their responses to disease severity. Methods: Nasopharyngeal aspirations (NPAs) were analyzed for RSV and IL-1, IL-2, IL-4, IL-5, IL-6, IL-10, IL-12, IL-1RA, IL-4R, IFN-, sTNFR1, sTNFR2, and TNF-α. Clinical data were collected from the medical records. Results: We included 331 infants of whom 214 were RSV+. In comparison to RSV-infants, they had significantly higher levels of TNF-, IL-6, IL-1, and IFN- (p < 0.05). This also applied to anti-inflammatory cytokine IL-10 levels, but these levels were remarkably lower than levels of TNF-, IL-6, and IL-1. sTNFR1/2 were significantly increased in RSV+ infants. Hospitalized patients had significantly higher levels of TNF-, sTNFR2, and IL-10 (p < 0.05) than non-hospitalized patients. The cytokine response could not be related to disease severity. We found no evidence of a skewed Th1/Th2 immune profile. Conclusion: In acute RSV disease, infected infants' NPAs contain a significant amount of pro-inflammatory cytokines. Whether this response is beneficial or deleterious remains unanswered. Interpersonal variations in cytokine responses might be linked to an inherited tendency to variations in disease severity.
INTRODUCTION
A number of findings suggest that the variability in the severity of respiratory syncytial virus (RSV) infections may be rooted in individual differences in inflammatory response [1, 2] and not to RSV polymorphisms (http://www.ncbi.nlm.nih.gov/sites/entrez?Db=genome& Cmd=ShowDetailView&TermToSearch=11728).
Ex vivo studies have focused on cytokine production by cord blood cells [3] [4] [5] [6] or peripheral blood mononuclear cells [7] [8] [9] , or they have measured cytokines in serum [10] . The direct clinical applicability of these results, however, remains, questionable since RSV has never been reported to cause a viremic phase.
In vivo human studies of cytokine levels in airway specimens from RSV+ infants indicate a pronounced production of inflammatory and immunoregulating cytokines such as interleukin (IL-)-2, IL-5, IL-6, IL-8, IL-9, IL-10, IL-11, tumor necrosis factor (TNF), Regulated on Activation Normal T-cell Expressed and Secreted (RANTES), and Eosinophil Cationic Protein (ECP) [11] [12] [13] . However, the clinical significance has been difficult to ascertain since the majority of these studies report unsystematic measurements of cytokine candidates in small groups of patients. Moreover, only a few studies have included an appropriate control group.
We studied a large cohort of 0 -36-month-old infants with acute upper and/or lower respiratory tract infection with the purpose of characterizing the magnitude of their disease symptoms during winter seasons. We evaluated the cytokine response in nasal pharyngeal aspirations (NPAs) to characterize the cytokine responses in RSV+ infants compared to RSV-infants, and to relate cytokine levels to disease severity. ber-March) from [2000] [2001] [2002] [2003] . The children were admitted due to symptoms of acute upper and/or lower respiratory tract infection (URTI/LRTI), i.e. wheezing, increased respiratory rate (RR), asthmatic breathing, rales, crackles, dyspnea, apnea, cyanosis.
Exclusion Criteria
We excluded patients undergoing treatment with corticosteroids or agents with possible symptomatic effects on respiratory symptoms, i.e. β2-agonists and antibiotics, and patients with recurrent episodes of bacterial pneumonia, chronic inflammatory diseases, immune deficiencies, chromosome aberrations, and congenital cardiopulmonary diseases, e.g. congenital heart disease (CHD) and bronchopulmonary dysplasia (BPD).
Study Design
This study was designed as an open, one-center cohort study.
PROCEDURES

Inclusion
The principal investigator examined all eligible patients within 24 hours after referral to the PER. The following baseline information was collected: Gestational age at time of birth (GA), birth weight (BW), known presence of chronic lung disease (BPD, cystic fibrosis, asthma, etc.), asthmatic bronchitis, atopic disease, disposition to allergy and/or asthma, and duration of respiratory symptoms before referral to the PER.
The physical examination focused on weight (W), height (H), rectal body temperature (Tp), transcutaneous oxygen saturation (SAT) (without supplemental oxygen being provided), skin color, RR, retractions of the chest wall, flaring of alae nasi, and use of accessory muscles during inspiration. C-reactive protein (CRP), pH, partial pressure of oxygen, and carbon dioxide were measured. Decisions on treatment of the included infants, time of discharge, and the need for clinical outpatient follow-up were left at the discretion of the house officer on duty.
After discharge, the following information was extracted from the medical records: date of discharge, length of stay (LOS) in hospital, RSV test result, confirmed positive culture of a representative tracheobronchial aspiration (TBA) or blood, antibiotic treatment, bronchodilators, steroids, supplemental oxygen, nasal continuous positive airway pressure (n-CPAP), mechanical ventilation, and death.
Sampling Technique
NPAs were sampled by introducing a catheter (charriére 08, Unoplast A/S, Denmark) attached to a sterile trachea suction unit (Maersk Medical A/S, Denmark) into the nostrils to the nasopharynx and subsequently applying vacuum (25 cm H 2 O) during a 5-second retraction of the catheter. The catheter was flushed into the sterile mucus trap with 2 ml sterile, isotonic sodium chloride, which was immediately placed on ice and transported to our laboratories.
The samples were weighed using a precision scale weight (Mettler Toledo, Dual Range, Precision 0.01g) and centrifuged at 440 g for 10 minutes at 4˚C. The supernatants were separated from cell pellets by decantation in toto into another sterile tube and briefly homogenized. Aliquots of 250 l of the supernatant were transferred to 5 -6 sterile cryo tubes (NUNC A/S, Denmark) containing 20 l 10% azide, gently turned several times, and immediately frozen at -80˚C until final batch-wise cytokine analysis. The pellet was resuspended in 0.5 ml Phosphate-Buffered Saline (PBS) and kept at 4˚C until RSV examination within less than 12 hours. The analysis was performed by direct immunofluorescence (DIF) staining (Merifluor  RSV, Meridian Bioscience Inc., Cincinnati, Ohio, USA) at the Department of Clinical Microbiology according to the manufacturer's instruction.
Analyses of Inflammatory Mediators
IL-4 and TNF-α (PeliKine Compact kits, CLB, Amsterdam, the Netherlands) and soluble TNF-receptor 1 (sTNFR1) and 2 (sTNFR2) (Quantikine  kits, R&D Systems, Abingdon, UK) were quantified in accordance with the manufacturers' manuals. The inter-and intra-assay coefficients of variability of all assays were <10%. All cytokine analyses were carried out in duplicate. The detection limit of the enzyme-linked immunosorbent assays (ELISAs) used ranged from 0.4 -3.0 pg/ml. IL-1 receptor antagonist (IL-1Ra) and sIL-4R were measured in duplicate by an in-house double-sandwich ELISA using monospecific polyclonal antibodies to purified recombinant cytokines. Briefly, immuno-Maxisorp plates (Nunc, Roskilde, Denmark) were coated with protein-A affinity-purified IgG. The plates were blocked with 1% human serum albumin in PBS. The assays were calibrated with international standards of the respective cytokines (National Institute for Biological Standards and Controls, Potters Bar, Herfordshire, UK). Biotinylated rabbit antibodies were used as detecting antibodies along with streptavidin-peroxidase (Kirkegaard and Perry La., Gaithersburg, MD, USA). Development was carried out with 1,2-phenylenediamine dihydrochloride and measured at 492 nm. The inter-and intra-assay coefficients of variability for the concentration range [15.0 pg/mL -1.0 ng/mL] were <15%.
IL-2, IL-4, IL-5, IL-10, TNF-α and interferon-γ (IFN-γ) were quantified in duplicate by use of the Human T-helper 1 and 2 (Th1/Th2) Cytokine Cytometric Bead Array kit (Becton Dickinson (BD) Biosciences Pharmingen, San Diego, California, USA) in accordance with the manufacturer's manual.
Ethics
The local ethics committee (1999-1-1) and the Danish Data Management (2000-41-0313) approved the study, and written, informed consent was obtained from the parents of all patients before participation.
Statistical Analyses
Data were computed with SPSS Version 11.5 (SPSS Inc, Chicago, Illinois). The distribution was significantly different from a normal distribution (Kolmogorov-Smirnov with Lilliefors Significance Correction and ShapiroWilk had p-values < 0.001), and consequently non-parametric statistical methods were applied.
The Mann-Whitney U-test was used for two-independent-samples tests of cytokine levels in the following groups: 1) RSV+/RSV-; 2) female/male; and 3) hospitalized/non-hospitalized. Contingency tables were analyzed using Fisher's exact test for calculations involving groups < 5; otherwise Yates' corrected chi-square was applied. For numeric and non-parametric continuous data, Spearman's rho was calculated.
RESULTS
Description of Cohort
Figure 1 provides an overview of the 361 screened study patients. We recruited 331 infants of whom 158 (48%) were girls. Table 1 shows baseline characteristics of the cohort. Episodes of asthmatic bronchitis treated with bronchodilators and/or steroids had been present in 17% of the infants. Atopic diseases, diagnosed by a physician, were present in 20%, and 49% were predisposed for such disease, since asthma and/or allergy defined as > 1 positive skin provocation test had been diagnosed in first-degree siblings and/or parents.
Physical examination revealed that 49 (15%) of the infants had normal skin color, 83 (25%) had flushing, 192 (58%) had paleness, and 5 (1.5%) had cyanosis of the extremities. Significant subcostal chest wall retractions were present in 258 (78%), 54 (16%) had none, whereas 17 (5%) had minor localized suprasternal, supraclavicular, or intercostal retractions without involvement of the subcostal tissue.
Only 59 (18%) were immediately discharged as outpatients, whereas 272 (83%) were hospitalized. The hospitalized infants were significantly younger (p < 0.001), were generally more premature at birth (p = 0.030), and had a lower SAT (p < 0.007) and a higher RR (p = 0.034) than out-patients ( Table 2 ). Almost 2/3 (65%, n = 214) of the included infants (n = 331) were RSV+, while the remaining 117 (35%) were RSV-.
RSV+ infants were significantly younger than RSVinfants, had increased RR upon admission, and were hospitalized longer (Table 3) . However, we found no significant differences between RSV+ and RSV-infants in terms of clinical or paraclinical parameters (i.e., GA, BW, duration of symptoms before referral, Tp, SAT, Creactive protein [ Nearly all of the hospitalized infants (97%, 263/272) received inhalations with bronchodilators, 17% (45/272) were treated with corticosteroids, and 11% (31/272) had additional fluid administered either intravenously or orally through a nasogastric tube. Hospitalized infants treated with n-CPAP (18%, 50/272) had significantly lower age, longer LOS, and higher RR compared to nonn-CPAP-treated infants (not shown). They also had significantly lower GA and BW. At the time of n-CPAP treatment, they had respiratory acidosis with lower pH and higher pCO 2 values than non-hospitalized patients (data not shown). None of the patients died during hospitalization. 
Analyses of Cytokines in Nasopharyngeal Aspirations
The nasopharyngeal aspirates from RSV+ infants contained significantly higher levels of the pro-inflammatory mediators TNF-α, IL-6, IL-1β, and IFNγ (Figures 2(a)-(d) ) than those of RSV-infants. Though the same applied to the levels of the anti-inflammatory cytokine IL-10 (Figure 2(e) ), the IL-10 levels were remarkably lower than those of TNF-α, IL-6 and IL-1β.
We also measured the levels of sTNFR1 and sTNFR2, which correlated significantly in 35 randomly selected patients (Spearman's rho 0.950, p < 0.001, not shown). We therefore proceeded with in-depth analyses of sTNFR2 only. The levels of this receptor were also increased in RSV+ infants (Figure 2(f) ).
The levels of TNF-α, sTNFR2, and IL-10 ( Figures  3(a) -(c)) were higher in hospitalized infants than in out-patients. This was not the case for the other cytokines tested (data not shown).
No significant differences in cytokine levels were found upon subgroup analysis of the cohort stratified into 1) age groups: young infants: 0 -2 months, infants: 3 -11 months, and young children: 12 -36 months; 2) n-CPAP treatment: n-CPAP+, n-CPAP-; 3) bacterial contamination in TBA; 4) degree of retractions: suprasternal, supraclavicular, intercostal, subcostal; or 5) scoring of skin color: normal, flushing, paleness, cyanosis (not shown).
Th1/Th2-Related Cytokines
To further characterize the Th1/Th2 profile of the cy--tokines in NPAs, we made a computerized random selection of approximately 60 samples to be tested for IL-2, IL-4, IL-5, IL-12, and sIL-4R.
The measured levels were either very low (maximum concentrations of IL-12 < 70 pg/ml) or below detectable thresholds (IL-2, IL-4, IL-5, and sIL-4R).
Cytokine Profile versus Severity of Disease
We performed statistical analysis of subgroups of the study cohort divided into 1) eligible RSV+ patients, aged 0 -6 months and 2) eligible RSV+ patients, aged 0 -3 months, in order to spot possible deviations in cytokine profile as reflected by their disease severity. We found no statistically significant differences in either subgroup when correlating with the measured cytokines between infants with 1) very short (≤1 day) vs long (≥2 days) hospitalization; 2) short (≤2 days) vs long (≥3 days) hospitalization; 3) normocapnia vs hypercapnia; or 4) with no need for respiratory support (-n-CPAP) vs need for respiratory support (+n-CPAP) (data not shown).
DISCUSSION
We examined a large group of infants with acute respiratory distress referred to the PER for immediate pediatric evaluation during three winter seasons in Denmark.
Most infants had been ill for approximately one week upon referral. Hospitalized infants constituted almost 83%. Compared to the non-hospitalized group, they were younger and had clinical symptoms indicating more severe disease, e.g. lower SAT and higher RR. The majority of these infants were RSV+ and they were significantly younger than the RSV-infants, which is in line with the notion that RSV infection results in more serious illness at younger age [14] .
Apart from younger age, other well-known risk factors include prematurity, congenital heart disease, lung disease, and immunodeficiency. However, it has been difficult to identify reliable prognostic factors for development of severe disease in previously healthy infants [15] .
A number of cytokine gene polymorphisms may be associated with severe RSV disease, and high levels of inflammatory cytokines in RSV-infected infants have previously been demonstrated in both acute URTI [16] and RSV-related bronchiolitis [17] . However, it has not been thoroughly investigated whether the degree of inflammation, as measured by the levels of these mediators, predicts the clinical course of the disease. Specific cytokine profiles associated with RSV-infection have not been reported. In general, it has not been shown whether the inflammatory response seen upon RSV infection differs from the response to other viruses, and whether this reaction is beneficial or deleterious [18] . In fact, the immaturity of the infant immune system may alter the outcome of this viral infection, but at the same time, the viral infection possibly shapes the development of the infant's immune system and its future responses [19] .
In our cohort, we found a predominantly pro-inflamematory cytokine response in NPAs from RSV+ infants that was significantly different from that found in RSVinfants. In particular, TNF-α, IL-6, and IL-1β were found at concentrations likely to be of pathogenic importance. These findings are consistent with the previous observation that RSV binding to Toll-like receptor (TLR)-4 in airway epithelium may result in release of pro-inflamematory cytokines through activation of nuclear factorkappa B [20] , which controls the expression of numerous RSV-inducible inflammatory and immunomodulatory genes. However, multiple TLRs activate the innate immune system upon RSV infection, and though TLR activation may cause a specific cytokine production, viral factors may well counteract these pathways, thereby contributing to RSV proliferation [21] .
Despite the finding of elevated concentrations of inflammatory cytokines in RSV+ infants along with the observation that these infants needed longer hospitalize-tion than RSV-infants, we were unable to demonstrate any direct correlation between the level of inflammatory cytokines and the severity of pulmonary symptom scores.
Due to the association between the development of asthma and severe RSV infection, researchers have speculated whether the immune response elicited upon RSV is a Th2-predominant phenotype. Though animal models have indicated a skewed Th1/Th2 cytokine balance in RSV-related disease, this observation has not yet been systematically confirmed in humans [22, 23] . An excess type 2 immune response during RSV bronchiolitis has been suggested based on ratios of Th1-and Th2-related cytokines from nasal lavage fluid and stimulated PBMC [22] . Similarly, Th2 responses have been detected in NPA from children during viral lower respiratory tract infection, but these responses were not unique for RSV infection [24] .
We found very low levels of Th1-and Th2-related cytokines. Even though the concentrations of IFN-γ and IL-10 were significantly higher in RSV+ than in RSVinfants, they were so low that a biological effect must be doubtful. IL-10 is known to down-regulate pro-inflamematory and to upregulate anti-inflammatory mediatorsincluding the shedding of sTNFR2. This soluble receptor has a dual action, since it serves as an effective inhibitor of ligand activity (here: TNF-α) at high concentrations, and acts as a facilitator of ligand-binding at low concentrations. To our knowledge, the present study is the first to show sTNFR2 in infants with RSV infection. Although the levels were significantly higher in RSV+ infants, they were within the lower range of that seen in sera of healthy children and in children with inflammatory conditions [25, 26] . Along with the fact that TNF concentrations were highly elevated in the airway secretion, this suggests that at the levels found here sTNFR2 is unlikely to effectively suppress TNF-α activity in the airway secretion of these patients. On the contrary, one may speculate that the sTNFR2 levels may facilitate TNF-α activity in airway secretion. We were unable to further substantiate this, since the ratio of TNF-α to sTNFR2 did not correlate with the clinical severity of disease.
During the acute phase, RSV infection seems to be characterized by a predominantly pro-inflammatory immune response. We demonstrated no association between the level of pro-inflammatory cytokines and the clinical severity of the infection. However, the cytokines observed in airway secretions from these patients may be involved in the pathogenesis of RSV-associated bronchiolitis-or they may represent an appropriate defense mechanism against the viral infection. Thus, it remains unanswered whether the cytokines measured are to be considered "friend" or "foe".
In conclusion, this large-scale prospective study of patients aged 0 -36 months with symptoms of URTI/LRTI provides evidence of a predominantly pro-inflammatory cytokine response in RSV+ infants significantly different from that encountered in RSV-infants. RSV+ infants also had significantly higher concentrations of sTNFR2, a finding not previously reported. However, the data do not suggest that cytokine profiling of airway secretions can be used as a prognostic tool for determining the risk of developing severe disease manifestations in a clinical setting.
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